 CAMBRIDGE, Mass.--BUSINESS WIRE--VBI Vaccines Inc. Nasdaq: VBIV VBI, a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, President and Chief Executive Officer, and David E. Anderson, Ph.D., Chief Scientific Officer, will participate in an analyst-led fireside chat at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17 at 10:40 AM ET. Presentation Details: - Event: Oppenheime 